A high hemoglobin glycation index (HGI) has been repeatedly associated with greater risk for hypoglycemia in people with diabetes and greater risk for chronic vascular disease in people with or without diabetes. This review explores how different sources of analytical and biological variation in HbA1c and blood glucose individually and collectively affect the clinical information value of HGI. We conclude that HGI is a complex quantitative trait that is a clinically practical biomarker of risk for both hypoglycemia and chronic vascular disease. Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
James M Hempe, Daniel S Hsia. Variation in the hemoglobin glycation index. Journal of diabetes and its complications. 2022 Jul;36(7):108223
PMID: 35667965
View Full Text